Vaccines are a tool, not a silver bullet. Off-label treatment choices must be considered.

theglobeandmail.com
January 2, 2022

A scientific call: expand our pandemic response to include early outpatient treatment with repurposed drugs for COVID-19. Presenting the vastness of scientific evidence supporting the use of fluvoxamine in COVID-19 treatment.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!